AI-guided solutions to
improve health outcomes for
mothers and their babies

Read More

Oli: Working to address unmet needs in women’s health

Oli has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

Oli PPH is the only product to ever identify individuals who are at higher risk of developing postpartum hemorrhage well before they give birth.

Oli PPH is aiming to save lives and reduce the occurrence of irreversibly debilitating outcomes such as emergency hysterectomy, associated with the leading cause of preventable maternal death.
During pregnancy and labour, women today are monitored with technologies similar to what was used on their grandmothers.
2.4x more mothers are dying in the USA today compared to 30 years ago, and globally 2.6M  babies die each year from stillbirth, with little improvement in decades
Oli aims to provide an opportunity to enable what no other device can today - dramatically reduce the unacceptably high rate of preventable complications and deaths during pregnancy and labour
Image
Founded after a traumatic
birth experience.
Determined to prove to the world
we can do better.

Latest News

Baymatob has successfully completed a competitive selection process to be awarded a grant in the inaugural cohort of the CUREator+ accelerator program. This program, funded by the Australian...

Baymatob is honoured to have been awarded as the AI Innovator in Healthcare at the 2024 Australian AI Awards. Our AI-driven solutions are transforming healthcare by improving health outcomes for...

Baymatob is very happy to share that Lisa McIntyre and Tamara Mills have been appointed as non-executive directors of the company in March 2024. “ We are fortunate to have been able to attract two...